These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25131043)

  • 1. Use of IGL-1 preservation solution in liver transplantation.
    Wiederkehr JC; Igreja MR; Nogara MS; Goncalves N; Montemezzo GP; Wiederkehr HA; Wassen MP; Nobrega HA; Zenatti KB; Mori LY; Tudisco MS
    Transplant Proc; 2014; 46(6):1809-11. PubMed ID: 25131043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Direct Comparison Between Institut Georges Lopez 1 and Histidine-Tryptophan-Ketoglutarate Preservation Solutions in Liver Transplantation.
    Kiyoshi Takano de Saidneuy AE; Bruno de Rezende M; Rogerio de Oliveira Salvalaggio P
    Transplant Proc; 2020 Jun; 52(5):1262-1264. PubMed ID: 32507487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver Transplantation.
    Meine MH; Leipnitz I; Zanotelli ML; Schlindwein ES; Kiss G; Martini J; de Medeiros Fleck A; Mucenic M; de Mello Brandão A; Marroni CA; Craco Cantisani GP
    Transplant Proc; 2015 May; 47(4):888-93. PubMed ID: 26036479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK.
    Panisello-Roselló A; Verde E; Lopez A; Flores M; Folch-Puy E; Rolo A; Palmeira C; Hotter G; Carbonell T; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis.
    Szilágyi ÁL; Mátrai P; Hegyi P; Tuboly E; Pécz D; Garami A; Solymár M; Pétervári E; Balaskó M; Veres G; Czopf L; Wobbe B; Szabó D; Wagner J; Hartmann P
    World J Gastroenterol; 2018 Apr; 24(16):1812-1824. PubMed ID: 29713134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relevance of the UPS in Fatty Liver Graft Preservation: A New Approach for IGL-1 and HTK Solutions.
    Panisello-Roselló A; Verde E; Amine Zaouali M; Flores M; Alva N; Lopez A; Folch-Puy E; Carbonell T; Hotter G; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcomes using two preservation solutions (UW/HTK) in liver transplantation from brain death donors].
    Martínez J; Bächler JP; Moisan F; Torres J; Duarte I; Pérez RM; Benítez C; Arrese M; Domínguez P; Guerra JF; Jarufe N
    Rev Med Chil; 2014 Oct; 142(10):1229-37. PubMed ID: 25601106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.
    Adam R; Delvart V; Karam V; Ducerf C; Navarro F; Letoublon C; Belghiti J; Pezet D; Castaing D; Le Treut YP; Gugenheim J; Bachellier P; Pirenne J; Muiesan P;
    Am J Transplant; 2015 Feb; 15(2):395-406. PubMed ID: 25612492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft Protection Against Cold Ischemia Preservation: An Institute George Lopez 1 and Histidine-tryptophan-ketoglutarate Solution Appraisal.
    Panisello-Rosello A; Castro-Benítez C; Lopez A; Balloji S; Folch-Puy E; Adam R; Roselló-Catafau J
    Transplant Proc; 2018 Apr; 50(3):714-718. PubMed ID: 29661422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors.
    Mangus RS; Fridell JA; Vianna RM; Milgrom MA; Chestovich P; Chihara RK; Tector AJ
    Liver Transpl; 2008 Mar; 14(3):365-73. PubMed ID: 18306380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation.
    Dondéro F; Paugam-Burtz C; Danjou F; Stocco J; Durand F; Belghiti J
    Ann Transplant; 2010; 15(4):7-14. PubMed ID: 21183870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation Using Prolonged Cold Ischemia Time Grafts Preserved With Institute George-Lopez-1 Solution.
    Wiederkehr JC; Igreja MR; Gonçalves N; Nogara M; Godoy M; Drago C; Massutti AM; Wiederkehr HA; Wiederkehr BA
    Transplant Proc; 2018 Apr; 50(3):711-713. PubMed ID: 29661421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation.
    Hatano E; Kiuchi T; Tanaka A; Shinohara H; Kitai T; Satoh S; Inomoto T; Egawa H; Uemoto S; Inomata Y; Lang H; Oldhafer KJ; Ringe B; Pichlmayr R; Tanaka K; Yamaoka Y
    Clin Sci (Lond); 1997 Jul; 93(1):81-8. PubMed ID: 9279207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of canine liver grafts using HTK solution.
    van Gulik TM; Reinders ME; Nio R; Frederiks WM; Bosma A; Klopper PJ
    Transplantation; 1994 Jan; 57(2):167-71. PubMed ID: 8310502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation.
    Rayya F; Harms J; Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):891-4. PubMed ID: 18555073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of living donor liver preservation with HTK solution.
    Ringe B; Braun F; Moritz M; Zeldin G; Soriano H; Meyers W
    Transplant Proc; 2005; 37(1):316-9. PubMed ID: 15808629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation.
    Potdar S; Malek S; Eghtesad B; Shapiro R; Basu A; Patel K; Broznick B; Fung J
    Clin Transplant; 2004 Dec; 18(6):661-5. PubMed ID: 15516240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.
    Meine MH; Zanotelli ML; Neumann J; Kiss G; de Jesus Grezzana T; Leipnitz I; Schlindwein ES; Fleck A; Gleisner AL; de Mello Brandão A; Marroni CA; Cantisani GP
    Transplant Proc; 2006; 38(6):1872-5. PubMed ID: 16908310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: an update of the indiana university experience.
    Agarwal A; Powelson JA; Goggins WC; Milgrom ML; Fridell JA
    Transplant Proc; 2008 Mar; 40(2):498-501. PubMed ID: 18374113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation.
    Ko JS; Kim GS; Gwak MS; Yang M; Kim HK; Shin BS; Kim JK; Lee SK
    Transplant Proc; 2008 Dec; 40(10):3308-10. PubMed ID: 19100378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.